INVA FY 2011 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M+1.2% YoY

Gross Profit

$25M100.0% margin

Operating Income

-$110M-447.7% margin

Net Income

-$115M-470.6% margin

EPS (Diluted)

$-1.41

Cash Flow

Operating Cash Flow

-$88M

Free Cash Flow

-$92M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$259M

Total Liabilities

$346M

Stockholders' Equity

-$87M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$24M	+1.2%
Gross Profit	$25M	$24M	+1.2%
Operating Income	-$110M	-$78M	-40.1%
Net Income	-$115M	-$84M	-37.5%